Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative ImmunityReview Published on 2021-10-182022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, MERS, SARS, [키워드] Adaptive immune response Autoimmunity autoinflammatory disease characteristic component COVID-19 COVID-19 infection cytokine Cytokines Diseases dysregulation extreme generate hyperinflammation immune system inflammasome activation Inflammation Innate macrophages manifestation NLRP3 overlap Pathogenesis pathologic condition Pathologies pharmacological treatment responses target the cytokine storm therapeutic target triggering White blood cells [DOI] 10.3390/ijms222011241 PMC 바로가기 [Article Type] Review
Disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic in March–October 2020: An exploratory analysisResearch Article Published on 2021-10-062022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] Analysis association baseline Characteristics collected Combination convalescent plasma Czech Republic dataset Dexamethasone early phase Efficacy Evidence Exploratory analysis external validation Favipiravir hospital Hydroxychloroquine marker outcome pandemic Patient patients hospitalized performed pharmacological treatment positive predictor prognostic model progression Remdesivir required retrospective SARS-CoV-2 severity statistical model Support tested treated Treatment [DOI] 10.1371/journal.pone.0245103 PMC 바로가기 [Article Type] Research Article
Obsessive Compulsive Disorder During Coronavirus Disease 2019 (COVID-19): 2- and 6-Month Follow-Ups in a Clinical Trial코로나 바이러스 질병 2019 (COVID-19) 중 강박 장애가 임상 시험에서 2 개월 및 6 개월의 추적 관찰Clinical Trial Published on 2021-09-282022-08-13 Journal: International Journal of Neuropsychopharmacology [Category] 임상, [키워드] 113 patient 113 patients adjust CBT clinical clinician Cohort Contamination coronavirus disease Coronavirus disease 2019 COVID-19 Deterioration ERP evaluate evaluated exacerbated exposure Follow-up Health illness obsessions Impact increase obsessional content obsessions Obsessive-compulsive disorder Obsessive-compulsive symptom OCD OCD patient OCD patients pandemic Patient pharmacological treatment prevention Psychiatric psychiatric assessment Psychiatric patient replicated response Response Prevention Result Stress Symptom symptom severity the patient treated Treatment [DOI] 10.1093/ijnp/pyab024 PMC 바로가기 [Article Type] Clinical Trial
Antiviral therapy and immunotherapy of COVID-19코로나19의 항바이러스 요법과 면역 요법Review Published on 2021-09-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] SARS, 치료제, [키워드] administration antivirals benefit clinical trial clinical trials COVID-19 description drug Immunotherapy medication observational study pandemic Pathogenesis Patient pharmacological treatment stages suggested the disease therapy Treatment treatment of COVID-19 [DOI] 10.37201/req/s01.17.2021 PMC 바로가기 [Article Type] Review
Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid StudyObservational Study Published on 2021-08-012022-10-05 Journal: Journal of the American Medical Directors Associat [Category] SARS, 신약개발, 임상, [키워드] 95% CI 95% confidence interval Admission analyzed Care cause changes in clinics COVID-19 COVID-19 pandemic COVID-19 patient death declined Decreased demographics diagnosed with COVID-19 driving explain First wave geriatric Hospitalized In-hospital death incidence incidence rate less Lower Mortality mortality rate Non-COVID-19 non-COVID-19 patient observational study outcome over oxygen saturation pandemic Patient patients patients with COVID-19 pharmacological treatment Poisson regression model proportion remained risk setting Standardization survival survival rate the patient time Treatment vital sign vital signs Wave [DOI] 10.1016/j.jamda.2021.06.005 PMC 바로가기 [Article Type] Observational Study
Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive ReviewReview Published on 2021-07-052022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] bamlanivimab Care carried Clinical symptoms Colchicine Community Comprehensive conducted COVID-19 COVID-19 pandemic Critical death disease Disease progression disease spread Effect Efficacy FIVE Health Hospitalization hospitalizations inhaled budesonide Ivermectin Measures Mild Mild disease mild to moderate mitigate Moderate COVID-19 moderate disease Mortality Open-label Patient patients pharmacological treatment Placebo-controlled trials Randomized randomized study randomized trial reduced review risk factor SARS-CoV-2 Stage Treatment viral clearance Viral load [DOI] 10.3390/ijerph18137212 PMC 바로가기 [Article Type] Review
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study2020년 7월과 8월 페루 Iquitos에서 항 SARS-CoV-2 항체의 혈청 유병률: 인구 기반 연구Article Published on 2021-07-012022-09-11 Journal: The Lancet. Global health [Category] Fulltext, SARS, 변종, 진단, 치료기술, [키워드] 95% CI Abstract age Analysis anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody baseline Characteristics China city Community Consent COVID-19 design effect detection Effect eligible enrolled epidemic peak excluded FIVE Follow-up groups health worker health workers highest IgG and IgM IgM anti-SARS-CoV-2 antibodies incidence individual intensity Iquito Iquitos material mortality rate occurred Orient parent participant pharmacological treatment phlebotomy population-based cohort Prevalence Rapid Rapid test receiving Region Regional Reinfection respiratory respiratory symptom respiratory symptoms risk of infection SARS-CoV-2 transmission second wave Sensitivity and specificity Seroprevalence shown significant difference significant differences Spanish stratified Test tested the SARS-CoV-2 translation Transmissibility Transmission variant vulnerability Zhejiang [DOI] 10.1016/S2214-109X(21)00173-X PMC 바로가기 [Article Type] Article
Pharmacological Treatment for the Management of COVID-19: A Narrative ReviewReview Article Published on 2021-06-302022-10-30 Journal: JNMA: Journal of the Nepal Medical Association [Category] COVID-19, [키워드] pharmacological treatment pharmacological treatment vaccines absence acute respiratory syndrome adopted antiviral agent article clinical trial coronavirus COVID 19 COVID-19 drugs effective Efficacy individual Infection infections measure mechanism of action Medicine narrative Nepal pandemic pharmacological treatment possession review treatment regimen Vaccine Vaccines was performed [DOI] 10.31729/jnma.5393 PMC 바로가기 [Article Type] Review Article
The importance of social zeitgeber in paediatric type 1 narcolepsy: What we can learn from the COVID‐19 restrictions adopted in Italy?Short Report Published on 2021-06-222022-10-30 Journal: Journal of Sleep Research [Category] Coronavirus, COVID19(2023년), MERS, SARS, [키워드] actigraphy adopted analysed Analysis body mass index changes in children COVID‐19 COVID‐19 difference Effect functional General population information Italian linear lockdown Narcolepsy New coronavirus no difference nocturnal pandemic Patient performed pharmacological treatment provided reduced scale sleep quality sleep–wake schedules sleepiness social jetlag sodium [DOI] 10.1111/jsr.13423 PMC 바로가기 [Article Type] Short Report
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?탄산수소효소 억제가 Covid-19 감염의 보완 요법으로 유용합니까?Brief Report Published on 2021-06-022022-09-10 Journal: Journal of Enzyme Inhibition and Medicinal Chemist [Category] SARS, 신약개발, 치료제, [키워드] acetazolamide affected affecting Blood carbonic anhydrase caused clinically CO2 complementary contagious contagious disease cough country COVID-19 COVID-19 outbreak COVID-19 patients disease dysregulated Factor Fever globe Healthcare system high-altitude pulmonary oedema hypothesise hypoxaemia hypoxia inhibitor oedema outbreak Patient patients pharmacological treatment problem pulmonary disease pulmonary oedema Shortness of breath similarity specific inhibitor Symptom therapy treat [DOI] 10.1080/14756366.2021.1924165 PMC 바로가기 [Article Type] Brief Report